Bruce Sargeant is the co-founder and CEO of Fusion Biotec Inc. The company provides a wide array of services, including early concept feasibility studies and systems engineering analysis through to the development of production-ready prototypes to clinical units for FDA 510(k) review. Fusion’s engineers are experts in developing complex analytical instrumentation for molecular and immunodiagnostic systems. The firm has also assisted numerous clients with FDA technical files, usability engineering, regulatory planning, and compliance testing.